{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:58:23Z","timestamp":1773763103533,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","pediatricnursing.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Nursing"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.pedn.2016.07.004","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T01:43:44Z","timestamp":1470275024000},"page":"723-735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Statins in the Management of Pediatric Dyslipidemia"],"prefix":"10.1016","volume":"31","author":[{"given":"Joyce L.","family":"Ross","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedn.2016.07.004_bb0005","series-title":"Repatha (evolocumab) prescribing information","author":"Amgen","year":"2015"},{"key":"10.1016\/j.pedn.2016.07.004_bb0010","series-title":"Crestor prescribing information","author":"AstraZeneca","year":"2014"},{"key":"10.1016\/j.pedn.2016.07.004_bb0015","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jacc.2009.10.042","article-title":"Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia","volume":"55","author":"Avis","year":"2010","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pedn.2016.07.004_bb0020","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM199806043382302","article-title":"Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa heart study","volume":"338","author":"Berenson","year":"1998","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pedn.2016.07.004_bb0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/oxfordjournals.aje.a113080","article-title":"Dynamic changes of serum lipoproteins in children during adolescence and sexual maturation","volume":"113","author":"Berenson","year":"1981","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.pedn.2016.07.004_bb0030","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1161\/01.CIR.91.9.2488","article-title":"Atherosclerosis: Basic mechanisms. Oxidation, inflammation, and genetics","volume":"91","author":"Berliner","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pedn.2016.07.004_bb0035","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jacl.2015.07.011","article-title":"Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study","volume":"9","author":"Braamskamp","year":"2015","journal-title":"Journal of Clinical Lipidology"},{"key":"10.1016\/j.pedn.2016.07.004_bb0040","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/j.atherosclerosis.2014.05.022","article-title":"Effect of rosuvastatin therapy on carotid intima media thickness in children with familial hypercholesterolemia: Findings from the charon study","volume":"235","author":"Braamskamp","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pedn.2016.07.004_bb0045","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jpeds.2015.05.006","article-title":"Efficacy and safety of pitavastatin in children and adolescents at high future cardiovascular risk","volume":"167","author":"Braamskamp","year":"2015","journal-title":"The Journal of Pediatrics"},{"key":"10.1016\/j.pedn.2016.07.004_bb0050","series-title":"Pravachol prescribing information","author":"Bristol-Myers Squibb","year":"2015"},{"key":"10.1016\/j.pedn.2016.07.004_bb0055","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1542\/peds.2004-2090","article-title":"Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia","volume":"116","author":"Clauss","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedn.2016.07.004_bb0060","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/01.ATV.18.6.1007","article-title":"Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadians with heterozygous familial hypercholesterolemia","volume":"18","author":"Couture","year":"1998","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pedn.2016.07.004_bb0065","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1542\/peds.2008-1349","article-title":"Lipid screening and cardiovascular health in childhood","volume":"122","author":"Daniels","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedn.2016.07.004_bb0070","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.jacl.2011.03.453","article-title":"Pediatric aspects of familial hypercholesterolemias: Recommendations from the National Lipid Association Expert Panel on familial hypercholesterolemia","volume":"5","author":"Daniels","year":"2011","journal-title":"Journal of Clinical Lipidology"},{"key":"10.1016\/j.pedn.2016.07.004_bb0100","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1161\/01.CIR.0000035247.42888.82","article-title":"Efficacy and safety of statin therapy in children with familial hypercholesterolemia: A randomized, double-blind, placebo-controlled trial with simvastatin","volume":"106","author":"de Jongh","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pedn.2016.07.004_bb0075","doi-asserted-by":"crossref","first-page":"160","DOI":"10.5863\/1551-6776-15.3.160","article-title":"Use of statins for dyslipidemia in the pediatric population","volume":"15","author":"Eiland","year":"2010","journal-title":"Journal of Pediatric Pharmacology and Therapeutics"},{"issue":"Suppl. 5","key":"10.1016\/j.pedn.2016.07.004_bb0080","first-page":"S213","article-title":"Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: Summary report","volume":"128","author":"Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents. National Heart Lung and Blood Institute","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedn.2016.07.004_bb0085","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2011.04.003","article-title":"Familial hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients: Clinical guidance from the National Lipid Association Expert Panel on familial hypercholesterolemia","volume":"5","author":"Goldberg","year":"2011","journal-title":"Journal of Clinical Lipidology"},{"key":"10.1016\/j.pedn.2016.07.004_bb0090","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jacl.2014.07.007","article-title":"National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 - executive summary","volume":"8","author":"Jacobson","year":"2014","journal-title":"Journal of Clinical Lipidology"},{"key":"10.1016\/j.pedn.2016.07.004_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2015.02.003","article-title":"National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 2","author":"Jacobson","year":"2015","journal-title":"Journal of Clinical Lipidology"},{"key":"10.1016\/j.pedn.2016.07.004_bb0105","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/jamapediatrics.2014.3216","article-title":"Prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents, 1999-2012","volume":"169","author":"Kit","year":"2015","journal-title":"JAMA Pediatrics"},{"key":"10.1016\/j.pedn.2016.07.004_bb0110","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1203\/00006450-199605000-00021","article-title":"Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia","volume":"39","author":"Knipscheer","year":"1996","journal-title":"Pediatric Research"},{"key":"10.1016\/j.pedn.2016.07.004_bb0115","series-title":"Livalo","author":"Kowa Pharmaceuticals America, I","year":"2015"},{"key":"10.1016\/j.pedn.2016.07.004_bb0120","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/jama.2014.8892","article-title":"Ten-year follow-up after initiation of statin therapy in children with familial hypercholesterolemia","volume":"312","author":"Kusters","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.pedn.2016.07.004_bb0125","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/CIRCULATIONAHA.106.176158","article-title":"Diet and lifestyle recommendations revision 2006: A scientific statement from the American Heart Association nutrition committee","volume":"114","author":"Lichtenstein","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pedn.2016.07.004_bb0130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0022-3476(03)00186-0","article-title":"Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: A multicenter, randomized, placebo-controlled trial","volume":"143","author":"McCrindle","year":"2003","journal-title":"The Journal of Pediatrics"},{"key":"10.1016\/j.pedn.2016.07.004_bb0135","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/01.ATV.17.1.95","article-title":"Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. The PDAY research group. Pathobiological determinants of atherosclerosis in youth","volume":"17","author":"McGill","year":"1997","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pedn.2016.07.004_bb0140","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1161\/01.CIR.103.11.1546","article-title":"Effects of nonlipid risk factors on atherosclerosis in youth with a favorable lipoprotein profile","volume":"103","author":"McGill","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pedn.2016.07.004_bb0145","series-title":"Mevacor prescribing information","author":"Merck","year":"2014"},{"key":"10.1016\/j.pedn.2016.07.004_bb0150","series-title":"Zocor prescribing information","author":"Merck","year":"2015"},{"key":"10.1016\/j.pedn.2016.07.004_bb0155","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJM198601163140302","article-title":"Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa heart study","volume":"314","author":"Newman","year":"1986","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pedn.2016.07.004_bb0160","doi-asserted-by":"crossref","first-page":"3478-3390a","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: Guidance for clinicians to prevent coronary heart disease: Consensus statement of the European atherosclerosis society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pedn.2016.07.004_bb0165","series-title":"Lescol prescribing information","author":"Novartis","year":"2012"},{"key":"10.1016\/j.pedn.2016.07.004_bb0170","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ahj.2013.12.008","article-title":"Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for awareness and DEtection of familial hypercholesterolemia registry","volume":"167","author":"O'Brien","year":"2014","journal-title":"American Heart Journal"},{"key":"10.1016\/j.pedn.2016.07.004_bb0175","series-title":"Lipitor prescribing information","author":"Pfizer","year":"2015"},{"key":"10.1016\/j.pedn.2016.07.004_bb0180","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.111.042523","article-title":"Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy","volume":"124","author":"Raal","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.pedn.2016.07.004_bb0185","series-title":"Praluent (alirocumab) prescribing information","author":"Regeneron","year":"2015"},{"key":"10.1016\/j.pedn.2016.07.004_bb0190","article-title":"Homozygous familial hypercholesterolemia. Role of NPs and PAs in achieving optimal outcomes using novel therapeutic interventions","author":"Ross","year":"2015","journal-title":"Clinicians Reviews, Supplements"},{"key":"10.1016\/j.pedn.2016.07.004_bb0195","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0735-1097(16)31856-3","article-title":"A randomized, double-blind, placebo-controlled, multi-center, cross-over study of rosuvastatin in children and adolescents (aged 6 to <18years) with homozygous familial hypercholesterolemia (HoFH)","volume":"67","author":"Stein","year":"2016","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pedn.2016.07.004_bb0200","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jama.281.2.137","article-title":"Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: A randomized controlled trial","volume":"281","author":"Stein","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.pedn.2016.07.004_bb0205","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1469-1809.2012.00724.x","article-title":"Low-density lipoprotein receptor gene familial hypercholesterolemia variant database: update and pathological assessment","volume":"76","author":"Usifo","year":"2012","journal-title":"Annals of Human Genetics"},{"key":"10.1016\/j.pedn.2016.07.004_bb0210","first-page":"CD006401","article-title":"Statins for children with familial hypercholesterolemia","volume":"7","author":"Vuorio","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pedn.2016.07.004_bb0215","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/oxfordjournals.aje.a117445","article-title":"Cardiovascular risk factors among third grade children in four regions of the United States. The CATCH study. Child and adolescent trial for cardiovascular health","volume":"141","author":"Webber","year":"1995","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.pedn.2016.07.004_bb0220","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0140-6736(04)15467-6","article-title":"Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia","volume":"363","author":"Wiegman","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pedn.2016.07.004_bb0225","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: Gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman","year":"2015","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pedn.2016.07.004_bb0230","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.292.3.331","article-title":"Efficacy and safety of statin therapy in children with familial hypercholesterolemia: A randomized controlled trial","volume":"292","author":"Wiegman","year":"2004","journal-title":"JAMA"}],"container-title":["Journal of Pediatric Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882596316301385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882596316301385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:16:50Z","timestamp":1760113010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882596316301385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0882596316301385"],"URL":"https:\/\/doi.org\/10.1016\/j.pedn.2016.07.004","relation":{},"ISSN":["0882-5963"],"issn-type":[{"value":"0882-5963","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statins in the Management of Pediatric Dyslipidemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedn.2016.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}